global gastroretentive drug delivery systems outsourcing market, gastroretentive drug delivery systems outsourcing market analysis, gastroretentive drug delivery systems outsourcing market trends, gastroretentive drug delivery systems outsourcing market forecast, gastroretentive drug delivery systems outsourcing market growth, gastroretentive drug delivery systems outsourcing market america
At what pace is the gastroretentive drug delivery systems outsourcing market growing, and what is its estimated value?
The gastroretentive drug delivery systems outsourcing market size has grown strongly in recent years. It will grow from $1.39 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the rising incidence of stomach and small intestine disorders, rising drug delivery systems, rising prevalence of gastric cancer, rise in government initiatives, and increase in the number of hospitals.
The gastroretentive drug delivery systems outsourcing market size is expected to see strong growth in the next few years. It will grow to $2.03 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increase in the number of ambulatory centers, the focus on patient compliance and convenience, the rising incidence of chronic diseases, increasing personalized medicine, and the growing aging population. Major trends in the forecast period include advancements in polymer science, formulation technologies, bioadhesive systems, novel polymers, drug release modifiers, the development of gastroretentive dosage forms, the integration of digital health technologies, smart gastroretentive systems, and targeted drug delivery.
Get Your Free Sample of The Global Gastroretentive Drug Delivery Systems Outsourcing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp
What are the key drivers behind the rapid expansion of the gastroretentive drug delivery systems outsourcing market?
The rising prevalence of gastrointestinal disorders is expected to propel the growth of the gastroretentive drug delivery systems outsourcing market going forward. Gastrointestinal disorders refer to a wide range of diseases affecting the digestive tract, which includes the stomach, liver, gallbladder, intestines, and pancreas. Gastrointestinal disorders are rising due to aging populations, antibiotic use, infectious agents, dietary changes, stress and lifestyle factors, and obesity. Outsourcing gastroretentive drug delivery systems provides pharmaceutical companies with the resources and expertise needed to address the growing burden of gastrointestinal disorders, ultimately improving patient outcomes and quality of life. For instance, in January 2023, according to the American Cancer Society (ACS), a US-based health organization dedicated to eliminating cancer, gastrointestinal cancers increased by 3.18% to 348,840 compared to 338,090 in 2021 in the United States.. Therefore, the rising prevalence of gastrointestinal disorders is driving the gastroretentive drug delivery systems outsourcing market.
What is the segmentation for the gastroretentive drug delivery systems outsourcing market?
The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –
1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users
Subsegments:
1) Floating Systems: Single Unit Systems, Multiple Unit Systems
2) Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers
3) Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems
Order your report now for swift delivery
Who are the most influential companies in the gastroretentive drug delivery systems outsourcing market?
Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.
What are the most influential trends expected to drive the gastroretentive drug delivery systems outsourcing market forward?
Major companies operating in the gastroretentive drug delivery systems outsourcing market are focused on developing innovative products, such as ready-to-fill (RTF) colon functional capsules to enhance drug delivery efficiency and patient convenience. The ready-to-fill (RTF) colon functional capsules refers to pre-manufactured, empty capsules that are designed to be filled with specific formulations or active ingredients tailored for the colon.. For instance, in September 2024, Evonik, a Germany-based leader in advanced drug delivery, launched EUDRACAP colon functional capsules, designed for the targeted delivery of oral drugs to the ileo-colonic region. These innovative capsules are the first ready-to-fill option available in the market, aimed at delivering sensitive active ingredients such as live biotherapeutic products (LBPs). Currently offered in technical grade, a GMP-grade product is also in development. EUDRACAP colon enhances the oral drug development process by simplifying formulation and accelerating time to market, making it a significant advancement in gastroretentive drug delivery systems.
What are the major regional insights for the gastroretentive drug delivery systems outsourcing market, and which region holds the top position?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Gastroretentive Drug Delivery Systems Outsourcing Market Report 2025 Offer?
The gastroretentive drug delivery systems outsourcing market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Gastroretentive drug delivery systems outsourcing refers to the practice of pharmaceutical companies contracting with external service providers or contract research organizations (CROs) to develop and manufacture drug delivery systems designed to prolong the residence time of medications within the gastrointestinal (GI) tract. These systems are engineered to enhance drug absorption, improve therapeutic efficacy, and optimize patient outcomes.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15813
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
